Alkeon Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-856,466
| Closed | -$12.4M | – | 127 |
|
|
2022
Q2 | $12.4M | Hold |
856,466
| – | – | 0.03% | 90 |
|
|
2022
Q1 | $15.8M | Hold |
856,466
| – | – | 0.03% | 97 |
|
|
2021
Q4 | $20.4M | Sell |
856,466
-14,960
| -2% | -$356K | 0.04% | 107 |
|
|
2021
Q3 | $21.5M | Hold |
871,426
| – | – | 0.04% | 111 |
|
|
2021
Q2 | $21.5M | Sell |
871,426
-3,574
| -0.4% | -$88.3K | 0.03% | 110 |
|
|
2021
Q1 | $19.1M | Hold |
875,000
| – | – | 0.03% | 108 |
|
|
2020
Q4 | $22.3M | Hold |
875,000
| – | – | 0.04% | 106 |
|
|
2020
Q3 | $24.6M | Buy |
875,000
+100,000
| +13% | +$2.81M | 0.05% | 99 |
|
|
2020
Q2 | $21.9M | Buy |
+775,000
| New | +$21.9M | 0.06% | 97 |
|